110 related articles for article (PubMed ID: 2113413)
1. alpha-Methyl-p-tyrosine pretreatment partially prevents methamphetamine-induced endogenous neurotoxin formation.
Axt KJ; Commins DL; Vosmer G; Seiden LS
Brain Res; 1990 May; 515(1-2):269-76. PubMed ID: 2113413
[TBL] [Abstract][Full Text] [Related]
2. The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat.
Marek GJ; Vosmer G; Seiden LS
Brain Res; 1990 May; 516(1):1-7. PubMed ID: 2142010
[TBL] [Abstract][Full Text] [Related]
3. Pargyline increases 6-hydroxydopamine levels in the neostriatum of methamphetamine-treated rats.
Marek GJ; Vosmer G; Seiden LS
Pharmacol Biochem Behav; 1990 May; 36(1):187-90. PubMed ID: 2112259
[TBL] [Abstract][Full Text] [Related]
4. alpha-Methyl-p-tyrosine partially attenuates p-chloroamphetamine-induced 5-hydroxytryptamine depletions in the rat brain.
Axt KJ; Seiden LS
Pharmacol Biochem Behav; 1990 Apr; 35(4):995-7. PubMed ID: 1971723
[TBL] [Abstract][Full Text] [Related]
5. 5,6-Dihydroxytryptamine, a serotonergic neurotoxin, is formed endogenously in the rat brain.
Commins DL; Axt KJ; Vosmer G; Seiden LS
Brain Res; 1987 Feb; 403(1):7-14. PubMed ID: 2435369
[TBL] [Abstract][Full Text] [Related]
6. 5-hydroxy-3-ethylamino-2-oxindole is not formed in rat brain following a neurotoxic dose of methamphetamine: evidence that methamphetamine does not induce the hydroxyl radical-mediated oxidation of serotonin.
Yang Z; Wrona MZ; Dryhurst G
J Neurochem; 1997 May; 68(5):1929-41. PubMed ID: 9109519
[TBL] [Abstract][Full Text] [Related]
7. Hypersensitivity to alpha-methyl-p-tyrosine suggests that behavioural recovery of rats receiving neonatal 6-OHDA lesions is mediated by residual catecholamine neurones.
Rogers DC; Dunnett SB
Neurosci Lett; 1989 Jul; 102(1):108-13. PubMed ID: 2506494
[TBL] [Abstract][Full Text] [Related]
8. Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons.
Marek GJ; Vosmer G; Seiden LS
Brain Res; 1990 Apr; 513(2):274-9. PubMed ID: 2140952
[TBL] [Abstract][Full Text] [Related]
9. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
Stone DM; Johnson M; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1988 Oct; 247(1):79-87. PubMed ID: 2902215
[TBL] [Abstract][Full Text] [Related]
10. Nigrostriatal dopamine actions on the D2 receptors mediate methamphetamine effects on the striatonigral substance P system.
Sonsalla PK; Gibb JW; Hanson GR
Neuropharmacology; 1986 Nov; 25(11):1221-30. PubMed ID: 2432440
[TBL] [Abstract][Full Text] [Related]
11. Effect of dopamine depletion upon the K(+)-evoked release of CCK from superfused striatal slices.
Sierralta J; Gysling K
Neurosci Lett; 1990 May; 112(2-3):313-7. PubMed ID: 2113658
[TBL] [Abstract][Full Text] [Related]
12. Endogenously produced 5,6-dihydroxytryptamine may mediate the neurotoxic effects of para-chloroamphetamine.
Commins DL; Axt KJ; Vosmer G; Seiden LS
Brain Res; 1987 Sep; 419(1-2):253-61. PubMed ID: 2445423
[TBL] [Abstract][Full Text] [Related]
13. Food intake of rats depleted of dopamine as neonates is impaired by inhibition of catecholamine biosynthesis.
Potter BM; Bruno JP
Neurosci Lett; 1989 Dec; 107(1-3):295-300. PubMed ID: 2515502
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of alpha-methyl-p-tyrosine and 6-hydroxydopamine on pentylenetetrazol seizures in mice.
Abed WT
Pharmacol Biochem Behav; 1986 Nov; 25(5):949-52. PubMed ID: 3097680
[TBL] [Abstract][Full Text] [Related]
15. Methamphetamine-induced decrease in neural glucocorticoid receptors: relationship to monoamine levels.
Lowy MT; Novotney S
Brain Res; 1994 Feb; 638(1-2):175-81. PubMed ID: 8199858
[TBL] [Abstract][Full Text] [Related]
16. Role of dopamine in the neurotoxic effects of methamphetamine.
Schmidt CJ; Ritter JK; Sonsalla PK; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1985 Jun; 233(3):539-44. PubMed ID: 2409267
[TBL] [Abstract][Full Text] [Related]
17. Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes.
Wagner GC; Lucot JB; Schuster CR; Seiden LS
Brain Res; 1983 Jul; 270(2):285-8. PubMed ID: 6883096
[TBL] [Abstract][Full Text] [Related]
18. [Changes in the dopamine content in the brain of Periplaneta americana L. after application of structural analogs of dopamine and reserpine].
Prée J; Rutschke E
Biomed Biochim Acta; 1983; 42(4):407-12. PubMed ID: 6226288
[TBL] [Abstract][Full Text] [Related]
19. Regulation of male rat copulatory behavior by preoptic incertohypothalamic dopamine neurons.
Bitran D; Hull EM; Holmes GM; Lookingland KJ
Brain Res Bull; 1988 Mar; 20(3):323-31. PubMed ID: 3130153
[TBL] [Abstract][Full Text] [Related]
20. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
Criswell HE; Johnson KB; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
